Chui Juanita Noeline, Kotecha Krishna, Gall Tamara Mh, Mittal Anubhav, Samra Jaswinder S
Department of Upper Gastrointestinal Surgery, Royal North Shore Hospital, Sydney 2065, NSW, Australia.
Faculty of Medicine and Health, University of Sydney, Sydney 2006, NSW, Australia.
World J Gastrointest Surg. 2023 May 27;15(5):834-846. doi: 10.4240/wjgs.v15.i5.834.
The management of high-grade pancreatic trauma is controversial.
To review our single-institution experience on the surgical management of blunt and penetrating pancreatic injuries.
A retrospective review of records was performed on all patients undergoing surgical intervention for high-grade pancreatic injuries [American Association for the Surgery of Trauma (AAST) Grade III or greater] at the Royal North Shore Hospital in Sydney between January 2001 and December 2022. Morbidity and mortality outcomes were reviewed, and major diagnostic and operative challenges were identified.
Over a twenty-year period, 14 patients underwent pancreatic resection for high-grade injuries. Seven patients sustained AAST Grade III injuries and 7 were classified as Grades IV or V. Nine underwent distal pancreatectomy and 5 underwent pancreaticoduodenectomy (PD). Overall, there was a predominance of blunt aetiologies (11/14). Concomitant intra-abdominal injuries were observed in 11 patients and traumatic haemorrhage in 6 patients. Three patients developed clinically relevant pancreatic fistulas and there was one in-hospital mortality secondary to multi-organ failure. Among stable presentations, pancreatic ductal injuries were missed in two-thirds of cases (7/12) on initial computed tomography imaging and subsequently diagnosed on repeat imaging or endoscopic retrograde cholangiopancreatography. All patients who sustained complex pancreaticoduodenal trauma underwent PD without mortality. The management of pancreatic trauma is evolving. Our experience provides valuable and locally relevant insights into future management strategies.
We advocate that high-grade pancreatic trauma should be managed in high-volume hepato-pancreato-biliary specialty surgical units. Pancreatic resections including PD may be indicated and safely performed with appropriate specialist surgical, gastroenterology, and interventional radiology support in tertiary centres.
高级别胰腺创伤的处理存在争议。
回顾我们单机构处理钝性和穿透性胰腺损伤的手术经验。
对2001年1月至2022年12月期间在悉尼皇家北岸医院接受高级别胰腺损伤(美国创伤外科学会[AAST]Ⅲ级或更高)手术干预的所有患者的记录进行回顾性分析。对发病率和死亡率结果进行评估,并确定主要的诊断和手术挑战。
在20年期间,14例患者因高级别损伤接受了胰腺切除术。7例患者为AASTⅢ级损伤,7例被分类为Ⅳ级或Ⅴ级。9例行胰体尾切除术,5例行胰十二指肠切除术(PD)。总体而言,钝性病因占主导(11/14)。11例患者伴有腹内损伤,6例患者有创伤性出血。3例患者发生临床相关的胰瘘,1例因多器官功能衰竭在院内死亡。在病情稳定的患者中,三分之二的病例(7/12)在初次计算机断层扫描成像时漏诊了胰管损伤,随后在重复成像或内镜逆行胰胆管造影时得以诊断。所有发生复杂胰十二指肠创伤的患者均接受了PD,无死亡病例。胰腺创伤的处理正在不断发展。我们的经验为未来的处理策略提供了有价值的、与当地相关的见解。
我们主张高级别胰腺创伤应在大容量的肝胆胰专科手术单元进行处理。在三级中心,包括PD在内的胰腺切除术在适当的专科手术、胃肠病学和介入放射学支持下可能是必要的且可安全实施。